

HY-18676B · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-18676B
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ILK-IN-2.html
Description
ILK-IN-2 OSU-T315 analog is an oral PDK2 inhibitor and also an ILK inhibitor, with an IC50 of 0.6 ?M. ILK-IN-2 induces cell autophagy and apoptosis, showing anti-tumor activity. ILK-IN-2 directly abolishes AKT activation by preventing AKT from translocating to lipid rafts, triggering Caspase-dependent apoptosis in chronic lymphocytic leukemia CLL and extending the lifespan in TCL1 mouse models.







